COMPOUNDS AND PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE AND ISCHEMIC BRAIN DISEASES

The invention relates to peptides comprising phycocyanobilin (PCB), as well as to the use of said peptides and PCB in medicine owing to the neuroprotective and/or neurogenerative effects thereof that have been identified. In addition, the invention relates to pharmaceutical combinations of said pept...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PARDO ANDREU, GILBERTO LAZARO, GUILLEN NIETO, GERARDO ENRIQUE, LOPEZ SAURA, PEDRO ANTONIO, PAVON FUENTES, NANCY, LLOPIZ ARZUAGA, ALEXEY, MUSACCHIO LASA, ALEXIS, RODRIGUEZ JIMENEZ, EFRAIN, BESADA PEREZ, VLADIMIR ARMANDO, PENTON ROL, GISELLE, PENTON ARIAS, EDUARDO, MARIN PRIDA, JAVIER, GONZALEZ LOPEZ, LUIS JAVIER
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PARDO ANDREU, GILBERTO LAZARO
GUILLEN NIETO, GERARDO ENRIQUE
LOPEZ SAURA, PEDRO ANTONIO
PAVON FUENTES, NANCY
LLOPIZ ARZUAGA, ALEXEY
MUSACCHIO LASA, ALEXIS
RODRIGUEZ JIMENEZ, EFRAIN
BESADA PEREZ, VLADIMIR ARMANDO
PENTON ROL, GISELLE
PENTON ARIAS, EDUARDO
MARIN PRIDA, JAVIER
GONZALEZ LOPEZ, LUIS JAVIER
description The invention relates to peptides comprising phycocyanobilin (PCB), as well as to the use of said peptides and PCB in medicine owing to the neuroprotective and/or neurogenerative effects thereof that have been identified. In addition, the invention relates to pharmaceutical combinations of said peptides and PCB with proteins or other peptides which, owing to the synergistic effect thereof, are suitable for use in the treatment of diseases of the central nervous system involving neurodegenerative and ischemic damage. La présente invention concerne des peptides comprenant de la phycocyanobiline (FCB), ainsi que l'utilisation à des fins médicales desdits peptides et de la FCB, compte tenu de leurs effets neuroprotecteurs et/ou neurorégénérateurs identifiés. En outre, l'invention concerne des combinaisons pharmaceutiques desdits peptides et de la FCB avec des protéines ou d'autres peptides qui, du fait de leur effet synergique, sont appropriés pour le traitement de maladies du système nerveux central avec lésion ischémique et neurodégénérative.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2838496C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2838496C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2838496C3</originalsourceid><addsrcrecordid>eNqFjLEKwjAQQLs4iPoN3g-4WBEdr5erOTCXkqSupUicihbq_2MRd6c3vMdbFgN51_hWTQRUA43F4JC4TUJ4hVlWopjEa4TaB0iWIQXG5FgT-BqU2-ANX1g5zN2NvxuJZNkJQRVQFIxExshxXSwe_TDlzY-rYltzIrvL46vL09jf8zO_O8L9qTwdzkcq_xcfOlc1_w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOUNDS AND PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE AND ISCHEMIC BRAIN DISEASES</title><source>esp@cenet</source><creator>PARDO ANDREU, GILBERTO LAZARO ; GUILLEN NIETO, GERARDO ENRIQUE ; LOPEZ SAURA, PEDRO ANTONIO ; PAVON FUENTES, NANCY ; LLOPIZ ARZUAGA, ALEXEY ; MUSACCHIO LASA, ALEXIS ; RODRIGUEZ JIMENEZ, EFRAIN ; BESADA PEREZ, VLADIMIR ARMANDO ; PENTON ROL, GISELLE ; PENTON ARIAS, EDUARDO ; MARIN PRIDA, JAVIER ; GONZALEZ LOPEZ, LUIS JAVIER</creator><creatorcontrib>PARDO ANDREU, GILBERTO LAZARO ; GUILLEN NIETO, GERARDO ENRIQUE ; LOPEZ SAURA, PEDRO ANTONIO ; PAVON FUENTES, NANCY ; LLOPIZ ARZUAGA, ALEXEY ; MUSACCHIO LASA, ALEXIS ; RODRIGUEZ JIMENEZ, EFRAIN ; BESADA PEREZ, VLADIMIR ARMANDO ; PENTON ROL, GISELLE ; PENTON ARIAS, EDUARDO ; MARIN PRIDA, JAVIER ; GONZALEZ LOPEZ, LUIS JAVIER</creatorcontrib><description>The invention relates to peptides comprising phycocyanobilin (PCB), as well as to the use of said peptides and PCB in medicine owing to the neuroprotective and/or neurogenerative effects thereof that have been identified. In addition, the invention relates to pharmaceutical combinations of said peptides and PCB with proteins or other peptides which, owing to the synergistic effect thereof, are suitable for use in the treatment of diseases of the central nervous system involving neurodegenerative and ischemic damage. La présente invention concerne des peptides comprenant de la phycocyanobiline (FCB), ainsi que l'utilisation à des fins médicales desdits peptides et de la FCB, compte tenu de leurs effets neuroprotecteurs et/ou neurorégénérateurs identifiés. En outre, l'invention concerne des combinaisons pharmaceutiques desdits peptides et de la FCB avec des protéines ou d'autres peptides qui, du fait de leur effet synergique, sont appropriés pour le traitement de maladies du système nerveux central avec lésion ischémique et neurodégénérative.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200107&amp;DB=EPODOC&amp;CC=CA&amp;NR=2838496C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200107&amp;DB=EPODOC&amp;CC=CA&amp;NR=2838496C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PARDO ANDREU, GILBERTO LAZARO</creatorcontrib><creatorcontrib>GUILLEN NIETO, GERARDO ENRIQUE</creatorcontrib><creatorcontrib>LOPEZ SAURA, PEDRO ANTONIO</creatorcontrib><creatorcontrib>PAVON FUENTES, NANCY</creatorcontrib><creatorcontrib>LLOPIZ ARZUAGA, ALEXEY</creatorcontrib><creatorcontrib>MUSACCHIO LASA, ALEXIS</creatorcontrib><creatorcontrib>RODRIGUEZ JIMENEZ, EFRAIN</creatorcontrib><creatorcontrib>BESADA PEREZ, VLADIMIR ARMANDO</creatorcontrib><creatorcontrib>PENTON ROL, GISELLE</creatorcontrib><creatorcontrib>PENTON ARIAS, EDUARDO</creatorcontrib><creatorcontrib>MARIN PRIDA, JAVIER</creatorcontrib><creatorcontrib>GONZALEZ LOPEZ, LUIS JAVIER</creatorcontrib><title>COMPOUNDS AND PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE AND ISCHEMIC BRAIN DISEASES</title><description>The invention relates to peptides comprising phycocyanobilin (PCB), as well as to the use of said peptides and PCB in medicine owing to the neuroprotective and/or neurogenerative effects thereof that have been identified. In addition, the invention relates to pharmaceutical combinations of said peptides and PCB with proteins or other peptides which, owing to the synergistic effect thereof, are suitable for use in the treatment of diseases of the central nervous system involving neurodegenerative and ischemic damage. La présente invention concerne des peptides comprenant de la phycocyanobiline (FCB), ainsi que l'utilisation à des fins médicales desdits peptides et de la FCB, compte tenu de leurs effets neuroprotecteurs et/ou neurorégénérateurs identifiés. En outre, l'invention concerne des combinaisons pharmaceutiques desdits peptides et de la FCB avec des protéines ou d'autres peptides qui, du fait de leur effet synergique, sont appropriés pour le traitement de maladies du système nerveux central avec lésion ischémique et neurodégénérative.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjLEKwjAQQLs4iPoN3g-4WBEdr5erOTCXkqSupUicihbq_2MRd6c3vMdbFgN51_hWTQRUA43F4JC4TUJ4hVlWopjEa4TaB0iWIQXG5FgT-BqU2-ANX1g5zN2NvxuJZNkJQRVQFIxExshxXSwe_TDlzY-rYltzIrvL46vL09jf8zO_O8L9qTwdzkcq_xcfOlc1_w</recordid><startdate>20200107</startdate><enddate>20200107</enddate><creator>PARDO ANDREU, GILBERTO LAZARO</creator><creator>GUILLEN NIETO, GERARDO ENRIQUE</creator><creator>LOPEZ SAURA, PEDRO ANTONIO</creator><creator>PAVON FUENTES, NANCY</creator><creator>LLOPIZ ARZUAGA, ALEXEY</creator><creator>MUSACCHIO LASA, ALEXIS</creator><creator>RODRIGUEZ JIMENEZ, EFRAIN</creator><creator>BESADA PEREZ, VLADIMIR ARMANDO</creator><creator>PENTON ROL, GISELLE</creator><creator>PENTON ARIAS, EDUARDO</creator><creator>MARIN PRIDA, JAVIER</creator><creator>GONZALEZ LOPEZ, LUIS JAVIER</creator><scope>EVB</scope></search><sort><creationdate>20200107</creationdate><title>COMPOUNDS AND PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE AND ISCHEMIC BRAIN DISEASES</title><author>PARDO ANDREU, GILBERTO LAZARO ; GUILLEN NIETO, GERARDO ENRIQUE ; LOPEZ SAURA, PEDRO ANTONIO ; PAVON FUENTES, NANCY ; LLOPIZ ARZUAGA, ALEXEY ; MUSACCHIO LASA, ALEXIS ; RODRIGUEZ JIMENEZ, EFRAIN ; BESADA PEREZ, VLADIMIR ARMANDO ; PENTON ROL, GISELLE ; PENTON ARIAS, EDUARDO ; MARIN PRIDA, JAVIER ; GONZALEZ LOPEZ, LUIS JAVIER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2838496C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>PARDO ANDREU, GILBERTO LAZARO</creatorcontrib><creatorcontrib>GUILLEN NIETO, GERARDO ENRIQUE</creatorcontrib><creatorcontrib>LOPEZ SAURA, PEDRO ANTONIO</creatorcontrib><creatorcontrib>PAVON FUENTES, NANCY</creatorcontrib><creatorcontrib>LLOPIZ ARZUAGA, ALEXEY</creatorcontrib><creatorcontrib>MUSACCHIO LASA, ALEXIS</creatorcontrib><creatorcontrib>RODRIGUEZ JIMENEZ, EFRAIN</creatorcontrib><creatorcontrib>BESADA PEREZ, VLADIMIR ARMANDO</creatorcontrib><creatorcontrib>PENTON ROL, GISELLE</creatorcontrib><creatorcontrib>PENTON ARIAS, EDUARDO</creatorcontrib><creatorcontrib>MARIN PRIDA, JAVIER</creatorcontrib><creatorcontrib>GONZALEZ LOPEZ, LUIS JAVIER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PARDO ANDREU, GILBERTO LAZARO</au><au>GUILLEN NIETO, GERARDO ENRIQUE</au><au>LOPEZ SAURA, PEDRO ANTONIO</au><au>PAVON FUENTES, NANCY</au><au>LLOPIZ ARZUAGA, ALEXEY</au><au>MUSACCHIO LASA, ALEXIS</au><au>RODRIGUEZ JIMENEZ, EFRAIN</au><au>BESADA PEREZ, VLADIMIR ARMANDO</au><au>PENTON ROL, GISELLE</au><au>PENTON ARIAS, EDUARDO</au><au>MARIN PRIDA, JAVIER</au><au>GONZALEZ LOPEZ, LUIS JAVIER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOUNDS AND PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE AND ISCHEMIC BRAIN DISEASES</title><date>2020-01-07</date><risdate>2020</risdate><abstract>The invention relates to peptides comprising phycocyanobilin (PCB), as well as to the use of said peptides and PCB in medicine owing to the neuroprotective and/or neurogenerative effects thereof that have been identified. In addition, the invention relates to pharmaceutical combinations of said peptides and PCB with proteins or other peptides which, owing to the synergistic effect thereof, are suitable for use in the treatment of diseases of the central nervous system involving neurodegenerative and ischemic damage. La présente invention concerne des peptides comprenant de la phycocyanobiline (FCB), ainsi que l'utilisation à des fins médicales desdits peptides et de la FCB, compte tenu de leurs effets neuroprotecteurs et/ou neurorégénérateurs identifiés. En outre, l'invention concerne des combinaisons pharmaceutiques desdits peptides et de la FCB avec des protéines ou d'autres peptides qui, du fait de leur effet synergique, sont appropriés pour le traitement de maladies du système nerveux central avec lésion ischémique et neurodégénérative.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2838496C
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title COMPOUNDS AND PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE AND ISCHEMIC BRAIN DISEASES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A28%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PARDO%20ANDREU,%20GILBERTO%20LAZARO&rft.date=2020-01-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2838496C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true